|Articles|November 16, 2011
- The Column-11-16-2011
- Volume 7
- Issue 21
Perfecting Processes in Drug Discovery
Author(s)Frederic Cheviron
Janet Kelsey of The Column spoke to Frédéric Cheviron, Sales & Marketing Manager for Chiral Technologies Europe, about the technology they use in drug development and how companies can improve their method development.
Advertisement
Janet Kelsey of The Column spoke to Frédéric Cheviron, Sales & Marketing Manager for Chiral Technologies Europe, about the technology they use in drug development and how companies can improve their method development.
Articles in this issue
about 14 years ago
Drug Discovery Advances Inextricably Linked to Specialty Gasesabout 14 years ago
Flow splitting to improve peak capacity in on-line LC×LCabout 14 years ago
The 'Inverse Van Gogh' Syndromeabout 14 years ago
Silky datingabout 14 years ago
Bird-brained molecular sexingabout 14 years ago
Sweet sweet cornNewsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on LCGC International
1
Identification of Human Decomposition VOCs in Concrete Evidence Using HS-SPME GC–MS
2
Mass Spectrometry–Driven Strategies for Membrane Protein–Targeted Drug Discovery
3
Advanced Mass Spectrometry Techniques for Complex Therapeutics
4
Silicon-Micro-Nanofabrication in Analytical Chemistry—Possibilities Beyond Micro-Pillar Array Columns
5